Regular review of injection sites by a clinician or diabetes specialist nurse is recommended for anyone on long-term injectable therapy
The FDAs requirements for obesity drugs include demonstration of clinically meaningful weight loss versus placebo, an acceptable safety profile, and sufficient long-term data
Studies of DSIP and its analogs over the past 30 years, since its discovery, indicate that DSIP is a unique member of the peptide neuromodulator family
An increase in the boost of natural energy in the body promotes exercise recovery, supports exercise performance, and boosts cellular efficiency
Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder
Women are affected considerably more